Göksel, S. Et Al. 2017. The Prognostic Significance of Metabolic Tumor Volume (MTV) and Total Lesion Glycolysis (TLG) with F18 FDG PET/CT in Non-Small Cell Lung Cancer (NSCLC). Annual Congress of the European Association of Nuclear Medicine, 2017 , (Vienna, Austria), 411.

Göksel, S., Yürekli, Y., & Cengiz, A., (2017). The Prognostic Significance of Metabolic Tumor Volume (MTV) and Total Lesion Glycolysis (TLG) with F18 FDG PET/CT in Non-Small Cell Lung Cancer (NSCLC) . Annual Congress of the European Association of Nuclear Medicine, 2017 (pp.411). Vienna, Austria

Göksel, SİBEL, Yakup Yürekli, And Arzu Cengiz. "The Prognostic Significance of Metabolic Tumor Volume (MTV) and Total Lesion Glycolysis (TLG) with F18 FDG PET/CT in Non-Small Cell Lung Cancer (NSCLC)," Annual Congress of the European Association of Nuclear Medicine, 2017, Vienna, Austria, 2017

Göksel, SİBEL Et Al. "The Prognostic Significance of Metabolic Tumor Volume (MTV) and Total Lesion Glycolysis (TLG) with F18 FDG PET/CT in Non-Small Cell Lung Cancer (NSCLC)." Annual Congress of the European Association of Nuclear Medicine, 2017 , Vienna, Austria, pp.411, 2017

Göksel, S. Yürekli, Y. And Cengiz, A. (2017) . "The Prognostic Significance of Metabolic Tumor Volume (MTV) and Total Lesion Glycolysis (TLG) with F18 FDG PET/CT in Non-Small Cell Lung Cancer (NSCLC)." Annual Congress of the European Association of Nuclear Medicine, 2017 , Vienna, Austria, p.411.

@conferencepaper{conferencepaper, author={SİBEL GÖKSEL Et Al. }, title={The Prognostic Significance of Metabolic Tumor Volume (MTV) and Total Lesion Glycolysis (TLG) with F18 FDG PET/CT in Non-Small Cell Lung Cancer (NSCLC)}, congress name={Annual Congress of the European Association of Nuclear Medicine, 2017}, city={Vienna}, country={Austria}, year={2017}, pages={411} }